9DC Stock Overview
Engages in the materials, medical/healthcare, smart, safety, engineering plastics, and other businesses in Japan, China, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 2/6 |
| Past Performance | 4/6 |
| Financial Health | 4/6 |
| Dividends | 4/6 |
Daicel Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥8.35 |
| 52 Week High | JP¥9.55 |
| 52 Week Low | JP¥6.75 |
| Beta | 0 |
| 11 Month Change | 3.73% |
| 3 Month Change | 11.33% |
| 1 Year Change | -6.18% |
| 33 Year Change | 32.54% |
| 5 Year Change | -10.22% |
| Change since IPO | -27.39% |
Recent News & Updates
Recent updates
Shareholder Returns
| 9DC | DE Chemicals | DE Market | |
|---|---|---|---|
| 7D | 5.0% | 1.1% | 1.1% |
| 1Y | -6.2% | 3.3% | 12.5% |
Return vs Industry: 9DC underperformed the German Chemicals industry which returned 3.3% over the past year.
Return vs Market: 9DC underperformed the German Market which returned 12.5% over the past year.
Price Volatility
| 9DC volatility | |
|---|---|
| 9DC Average Weekly Movement | 3.1% |
| Chemicals Industry Average Movement | 4.2% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 11.6% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 9DC has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: 9DC's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1919 | 11,134 | Yoshimi Ogawa | www.daicel.com |
Daicel Corporation engages in the materials, medical/healthcare, smart, safety, engineering plastics, and other businesses in Japan, China, and internationally. The company offers acetic acid, acetic acid derivative chemicals, acetate tow, acetic anhydride, thioglycolic acid, caprolactone derivatives, methyl 3-methoxyacrylate, cycloaliphatic epoxies, alkylamines comprising diethylhydroxyamine, and 1,3-butylene glycol, as well as cellulose acetate; and Actranza Lab, a drug delivery device. It also provides solutions for the electronics market, such as functional films and materials for use in smartphones, PCs, TVs, and in-vehicle displays; polymers and solvents for use in the semiconductor manufacturing process; optical lenses for use in VR, smartphones, and various sensors; printed electronic materials; and organic semiconductors.
Daicel Corporation Fundamentals Summary
| 9DC fundamental statistics | |
|---|---|
| Market cap | €2.34b |
| Earnings (TTM) | €348.93m |
| Revenue (TTM) | €3.50b |
6.7x
P/E Ratio0.7x
P/S RatioIs 9DC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 9DC income statement (TTM) | |
|---|---|
| Revenue | JP¥572.83b |
| Cost of Revenue | JP¥403.73b |
| Gross Profit | JP¥169.09b |
| Other Expenses | JP¥112.05b |
| Earnings | JP¥57.04b |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 206.80 |
| Gross Margin | 29.52% |
| Net Profit Margin | 9.96% |
| Debt/Equity Ratio | 74.8% |
How did 9DC perform over the long term?
See historical performance and comparisonDividends
4.0%
Current Dividend Yield25%
Payout RatioDoes 9DC pay a reliable dividends?
See 9DC dividend history and benchmarks| Daicel dividend dates | |
|---|---|
| Ex Dividend Date | Sep 27 2024 |
| Dividend Pay Date | Dec 04 2024 |
| Days until Ex dividend | 43 days |
| Days until Dividend pay date | 25 days |
Does 9DC pay a reliable dividends?
See 9DC dividend history and benchmarks